Background: The use of complementary/alternative medicine has garnered rising interest in recent years. Natural products including herbs, vitamins, and minerals are the most popularly consumed. The Internet is a ubiquitous source of information/market for these supplements. Aim: To systematically evaluate the dietary and herbal supplement recommended for patients with CKD and ESRD on the Internet, and try to distinguish between the claim of the manufacturer and proven scientific data. Methods: A questionnaire assessing each website was formulated. Each product ingredient was recorded in the questionnaire by two independent reviewers and statistically analyzed. Results: Of the 184 websites, 28% claimed to decrease CKD progression, 60% did not advise to consult a doctor before taking the supplement, and >90% did not mention any potential drug interaction, disease interaction, or caution in use during pregnancy or in children. The ten common plant ingredients claiming to be beneficial in kidney diseases were uva ursi, dandelion, parsley, corn silk, juniper, celery, buchu, horsetail, marshmallow, and stinging nettle. In contrast to their claims, these substances were not adequately studied in humans. The available animal studies showed detrimental effects and potential drug interactions with commonly used medications in the CKD/ESRD population. Conclusions: Nephrologists need to be cognizant of the lack of substantiated proven benefits of these substances and of the potential adverse effects in the animal models that can translate to the patients. Most importantly, the policy needs to change regarding the regulation of these products to prevent patient harm and misinformation. i 2014 S. Karger AG, Basel

1.
Isnard Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL: Herbs and the kidney. Am J Kidney Dis 2004;44:1-11.
2.
Peregoy JA, Clarke TC, Jones LI, Stussman BJ, Nahin RL: Regional variation in use of complementary health approaches by US adults. NCHS Data Brief 2014;146:1-8.
3.
American Botanical Council. Herbal Dietary Supplement Retail Sales Up 5.5 in 2012. 2014 (September 9, 2013).
4.
US Food and Drug Administration. Dietary Supplement. 2014 (May 22, 2014).
5.
Federal Trade Commission. Prepared Statement of the Federal Trade Commission Before the Subcommittee on Commerce, Manufacturing, and Trade of the House Energy and Commerce Committee on Elder Fraud and Consumer Protection Issues. 2014 (May 16, 2013).
6.
Debelle FD, Vanherweghem JL, Nortier JL: Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008;74:158-169.
7.
Tovar RT, Petzel RM: Herbal toxicity. Dis Mon 2009;55:592-641.
8.
National Kidney Foundation: Herbal Supplements and Kidney Disease, 2014.
9.
Grubbs V, Plantinga LC, Tuot DS, Hedgeman E, Saran R, Saydah S, Rolka D, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team: Americans' use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis 2013;61:739-747.
10.
Moolla A, Viljoen AM: ‘Buchu'-agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol 2008;119:413-419.
11.
Moghadam MH, Imenshahidi M, Mohajeri SA: Antihypertensive effect of celery seed on rat blood pressure in chronic administration. J Med Food 2013;16:558-563.
12.
Jakovljevic V, Raskovic A, Popovic M, Sabo J: The effect of celery and parsley juices on pharmacodynamic activity of drugs involving cytochrome P450 in their metabolism. Eur J Drug Metab Pharmacokinet 2002;27:153-156.
13.
Guo J, Liu T, Han L, Liu Y: The effects of corn silk on glycaemic metabolism. Nutr Metab (Lond) 2009;6:47.
14.
Zhao W, Yin Y, Yu Z, Liu J, Chen F: Comparison of anti-diabetic effects of polysaccharides from corn silk on normal and hyperglycemia rats. Int J Biol Macromol 2012;50:1133-1137.
15.
Hasanudin K, Hashim P, Mustafa S: Corn silk (stigma maydis) in healthcare: a phytochemical and pharmacological review. Molecules 2012;17:9697-9715.
16.
Ovadje P, Chatterjee S, Griffin C, Tran C, Hamm C, Pandey S: Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol 2011;133:86-91.
17.
Ju JB, Kim JS, Choi CW, Lee HK, Oh TK, Kim SC: Comparison between ethanolic and aqueous extracts from Chinese juniper berries for hypoglycaemic and hypolipidemic effects in alloxan-induced diabetic rats. J Ethnopharmacol 2008;115:110-115.
18.
Gonzalez-Castejon M, Visioli F, Rodriguez-Casado A: Diverse biological activities of dandelion. Nutr Rev 2012;70:534-547.
19.
Butani L, Afshinnik A, Johnson J, Javaheri D, Peck S, German JB, Perez RV: Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. Transplantation 2003;76:306-311.
20.
Koch E: Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Planta Med 2001;67:489-500.
21.
University of Maryland Medical Center. Horsetail. 2014 (May 7, 2013).
22.
Livestrong.com. Herbal Tea Remedies for a Kidney Cleanse. 2014 (August 16, 2013).
23.
Wang L, Del Priore LV: Bull's-eye maculopathy secondary to herbal toxicity from uva ursi. Am J Ophthalmol 2004;137:1135-1137.
24.
Chauhan B, Yu C, Krantis A, Scott I, Arnason JT, Marles RJ, Foster BC: In vitro activity of uva-ursi against cytochrome P450 isoenzymes and P-glycoprotein. Can J Physiol Pharmacol 2007;85:1099-1107.
25.
Gadi D, Bnouham M, Aziz M, Ziyyat A, Legssyer A, Legrand C, Lafeve FF, Mekhfi H: Parsley extract inhibits in vitro and ex vivo platelet aggregation and prolongs bleeding time in rats. J Ethnopharmacol 2009;125:170-174.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.